Life Length
Bensalem
About Life Length
World leader in the field of telomeres, Life Length offers a series of tests to measure cellular senescence, a crucial biological marker to establish biological age, for the early detection of chronic diseases and for risk stratification. Life Length is the only company in the world capable of measuring telomeres individually at a chromosomal level using its Telomere Analysis Technology® (TAT®). The company offers its testing services to relevant industries such the pharmaceutical for R & D and to carry out clinical studies, and also to doctors working in preventive medicine and personalized patient care in fields such as cardiology or oncology where telomeres have shown to make a significant contribution to the development of the disease. Life Length is accredited by the US Federal Government through CLIA as a clinical laboratory, it also holds the prestigious IS0 15189 accreditation and its ONCOCHECK project has received funds from the EU ‘Horizon 2020’ program under the financial agreement number 738707.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.2M
- Last round: Series Unknown (Oct 2023)
- Website: lifelength.com
- Phone: 1 (561) 886-6685
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/life-length-57594 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.